The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy

Immunotherapy and particularly immune checkpoint inhibitors have resulted in remarkable clinical responses in patients with immunogenic tumors, although most cancers develop resistance to immunotherapy. The molecular mechanisms of tumor resistance to immunotherapy remain poorly understood. We now sh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daniel Zingg, Natalia Arenas-Ramirez, Dilara Sahin, Rodney A. Rosalia, Ana T. Antunes, Jessica Haeusel, Lukas Sommer, Onur Boyman
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017-07-01
Colecção:Cell Reports
Assuntos:
immunotherapy
IL-2 complexes
anti-CTLA-4
anti-PD-1
tumor resistance
tumor immune escape
melanoma
epigenetics
EZH2
PRC2
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2211124717309464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados